Anebulo Pharmaceuticals I... (ANEB)
NASDAQ: ANEB
· Real-Time Price · USD
2.51
0.07 (2.87%)
At close: Aug 15, 2025, 3:59 PM
2.50
-0.40%
After-hours: Aug 15, 2025, 04:10 PM EDT
Anebulo Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.89M | -2.59M | -2.41M | -1.34M | -1.66M | -2.76M | -2.54M | -2.49M | -2.86M | -3.81M | -2.61M | -2.33M | -1.88M | -1.07M | -1.55M | -2.48M | -552K | -325K | -252K |
Interest Income | 102.26K | 7.07K | 26.01K | 50.22K | 68.08K | 75.52K | 55.2K | 6.00 | 79.15K | 8.82K | n/a | 1.93K | n/a | n/a | n/a | 1.02K | n/a | n/a | n/a |
Pretax Income | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M | -3.83M | -2.61M | -2.32M | -1.88M | -1.07M | -1.55M | -29.11M | -556K | -329K | -256K |
Net Income | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M | -3.84M | -2.61M | -2.32M | -1.88M | -1.07M | -1.55M | -29.11M | -556K | -329K | -256K |
Selling & General & Admin | 1.25M | 1.37M | 1.1M | 872.66K | 915.91K | 1.7M | 1.27M | 1.08M | 1.77M | 1.94M | 1.39M | 1.21M | 964.28K | 858.19K | 839.83K | 678.01K | 279.09K | 154.59K | 232.06K |
Research & Development | 638.32K | 1.22M | 1.31M | 467.71K | 748.34K | 1.06M | 1.27M | 1.42M | 1.09M | 1.87M | 1.22M | 1.12M | 915.36K | 212.94K | 715.1K | 1.81M | 273.04K | 169.98K | 20.29K |
Other Expenses | n/a | n/a | n/a | n/a | 2.32K | -594 | 7.66K | -1.2K | n/a | -13.83K | 212.00 | 813.00 | 3.15K | -1.87K | n/a | -1.34K | n/a | n/a | n/a |
Operating Expenses | 1.89M | 2.59M | 2.41M | 1.34M | 1.66M | 2.76M | 2.54M | 2.49M | 2.86M | 3.81M | 2.61M | 2.33M | 1.88M | 1.07M | 1.55M | 2.48M | 552.13K | 324.57K | 252.35K |
Interest Expense | 245.18K | 59.7K | 59.7K | 59.7K | 59.7K | 31.84K | n/a | 52.45K | n/a | n/a | n/a | 1.93K | n/a | 1.87K | n/a | n/a | 3.7K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 2.59M | 2.41M | 1.34M | 1.66M | 2.76M | 2.54M | 2.49M | 2.86M | 3.81M | 2.61M | 2.33M | 1.88M | 1.07M | 1.55M | 2.48M | 552.13K | 324.57K | 252.35K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -2.76K | n/a | n/a | n/a | 13.83K | n/a | -4.67K | -3.15K | 1.87K | n/a | -1.02K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M | 25.63M | 23.42M | 23.34M | 23.34M | 23.34M | 23.34M | 23.34M | 23.27M | 23.27M | 23.27M |
Shares Outstanding (Diluted) | 27.41M | 27.41M | 25.93M | 25.82M | 25.93M | 25.79M | 25.63M | 25.07M | 25.63M | 25.63M | 23.42M | 23.34M | 23.34M | 23.34M | 23.34M | 23.34M | 23.27M | 23.27M | 23.27M |
EPS (Basic) | -0.04 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.1 | -0.1 | -0.11 | -0.15 | -0.11 | -0.1 | -0.08 | -0.05 | -0.07 | -1.59 | -0.38 | -0.01 | -0.01 |
EPS (Diluted) | -0.06 | -0.09 | -0.08 | -0.05 | -0.06 | -0.11 | -0.1 | -0.1 | -0.11 | -0.15 | -0.11 | -0.1 | -0.08 | -0.05 | -0.07 | -1.59 | -0.38 | -0.01 | -0.01 |
EBITDA | -1.43M | -2.4M | -2.14M | -1.29M | -1.59M | -2.69M | -2.48M | -2.49M | -2.8M | -3.81M | -2.61M | 2.74K | -1.88M | -1.07M | -1.55M | -29.11M | -552K | -4.03K | -4.03K |
EBIT | -1.43M | -2.4M | -2.14M | -1.29M | -1.59M | -2.69M | -2.48M | -2.5M | -2.8M | -3.83M | -2.61M | -2.32M | -1.88M | -1.07M | -1.55M | -29.11M | -552K | -325K | -252K |
Depreciation & Amortization | 1.89M | 3.00 | 271.09K | 50.1K | 1.66M | 2.76K | 2.54M | 2.49M | 66.07K | 3.81M | 2.61M | 2.33M | 1.88M | 1.07M | 1.55M | 2.48M | 552.13K | 324.57K | 252.35K |